Drug Search Results
More Filters [+]


Alternative Names: sincalide, kinevac, cholecystokinin-8
Latest Update: 2023-08-08
Latest Update Note: News Article

Product Description

Sincalide is a synthetic C-terminal octapeptide identical to the sequences of the endogenous cholecystokinin hormone. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Sincalide)

Mechanisms of Action: Imaging Agent

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Canada | Ireland | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sincalide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events